Anesthesiology, Pain Medicine · Burlington, MA
NPI
1679679153
Since 2006
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
41 Mall Rd
Burlington, MA, 01805
Phone (781) 744-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$215K
2,763 services
Medicare patients, 2024
829
Average age 75
Drug cost, 2024
$362K
3,059 prescriptions
Company payments, 2025
$33.51
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew G Kowal was code 62323 (nerve block injection - back), 463 times for 312 patients. In total Andrew G Kowal billed 2,763 services in 41 codes, and Medicare paid $215K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 62323 Nerve Block Injection - Back | Facility | 463 | 312 | $78.62 | $36K |
| 99213 Office E&M - Established | Facility | 428 | 315 | $48.38 | $21K |
| 99214 Office E&M - Established | Facility | 183 | 158 | $76.80 | $14K |
| 64636 Destruction by Neurolytic Agent - Back | Facility | 180 | 160 | $68.96 | $12K |
| 64635 Destruction by Neurolytic Agent - Back | Facility | 178 | 161 | $229.66 | $41K |
| 64493 Nerve Block Injection - Back | Facility | 176 | 108 | $102.96 | $18K |
| 64494 Nerve Block Injection - Back | Facility | 172 | 106 | $57.90 | $9,958 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 114 | 88 | $13.84 | $1,578 |
| 27096 Joint Injection | Facility | 108 | 70 | $76.34 | $8,244 |
| 99204 Office E&M - New | Facility | 99 | 99 | $105.10 | $10K |
| 99203 Office E&M - New | Facility | 94 | 94 | $62.98 | $5,920 |
| 77002 Imaging - Miscellaneous | Facility | 92 | 69 | $21.82 | $2,007 |
| 20610 Joint Injection | Facility | 75 | 58 | $37.71 | $2,828 |
| 99152 Anesthesia | Facility | 67 | 57 | $9.95 | $667 |
| 62321 Nerve Block Injection - Back | Facility | 57 | 48 | $88.23 | $5,029 |
By year: 2022 $220K for 2,643 services; 2023 $230K for 2,844 services; 2024 $215K for 2,763 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrew G Kowal prescribed most often to Medicare patients was Tramadol Hcl, with 787 prescriptions and refills. In total Andrew G Kowal wrote 3,059 Medicare prescriptions that cost $362K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tramadol Hcl Generic | 787 | 811 | 187 | $6,914 |
| Pregabalin Generic | 643 | 796 | 155 | $16K |
| Gabapentin Generic | 336 | 485 | 86 | $5,430 |
| Tizanidine Hcl Generic | 220 | 272 | 69 | $5,914 |
| Celecoxib Generic | 114 | 180 | 32 | $1,801 |
| Tramadol Hcl Er Tramadol Hcl | 103 | 103 | 17 | $5,542 |
| Buprenorphine Generic | 99 | 99 | 25 | $21K |
| Savella Milnacipran Hcl | 84 | 130 | 19 | $64K |
| Nucynta Er Tapentadol Hcl | 72 | 72 | 12 | $112K |
| Oxycodone Hcl Generic | 57 | 57 | 13 | $525 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 53 | 53 | 15 | $1,062 |
| Cyclobenzaprine Hcl Generic | 53 | 56 | 13 | $524 |
| Nucynta Tapentadol Hcl | 52 | 52 | 16 | $73K |
| Diclofenac Sodium Generic | 43 | 51 | 11 | $1,062 |
| Duloxetine Hcl Generic | 33 | 75 | 13 | $1,094 |
Brand drugs: 285 claims; generic drugs: 2,774 claims; opioid claims: 1,315.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew G Kowal $33.51 ($33.51 in general payments such as food, travel and fees) from 1 company. The largest payer was Laborie Medical Technologies Corp. with $33.51.
| Company | Payments | Amount |
|---|---|---|
| Laborie Medical Technologies Corp. | 1 | $33.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.